Does Rallies show Form 4 insider transactions for RPTX?

Yes. Rallies tracks RPTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RPTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RPTX. It does not provide personalized investment advice.

RPTX (Repare Therapeutics Inc. Common Shares) Stock Analysis - Insider Trades

Repare Therapeutics Inc. Common Shares (RPTX) is a publicly traded Healthcare sector company. As of May 21, 2026, RPTX trades at $2.65 with a market cap of $114.24M and a P/E ratio of -1.19. RPTX moved +0.38% today. Year to date, RPTX is +46.41%; over the trailing twelve months it is +130.44%. Its 52-week range spans $0.89 to $4.07. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces RPTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RPTX stock inside the company?

Recent RPTX insider activity includes Koehler Maria sold 3.60K, Zinda Michael sold 5.61K, Forte Steve sold 6.88K, Segal Lloyd Mitchell sold 21.18K, and Segal Lloyd Mitchell sold 2.49K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RPTX Key Metrics

Key financial metrics for RPTX
Metric	Value
Price	$2.65
Market Cap	$114.24M
P/E Ratio	-1.19
EPS	$-2.23
Dividend Yield	0.00%
52-Week High	$4.07
52-Week Low	$0.89
Volume	1.22M
Avg Volume	0
Revenue (TTM)	$51.13M
Net Income	$-93.80M
Gross Margin	0.00%

Recent RPTX Insider Trades

Koehler Maria sold 3.60K (~$4.10K) on Mar 12, 2025.
Zinda Michael sold 5.61K (~$6.40K) on Mar 12, 2025.
Forte Steve sold 6.88K (~$7.85K) on Mar 12, 2025.
Segal Lloyd Mitchell sold 21.18K (~$24.14K) on Mar 12, 2025.
Segal Lloyd Mitchell sold 2.49K (~$11.53K) on Apr 1, 2024.

Latest RPTX News

Repare Therapeutics Shareholders Approve 99.76% Vote for XenoTherapeutics Acquisition — Jan 16, 2026

RPTX Analyst Consensus

9 analysts cover RPTX: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.00.

Common questions about RPTX

Who is trading RPTX stock inside the company?: Recent RPTX insider activity includes Koehler Maria sold 3.60K, Zinda Michael sold 5.61K, Forte Steve sold 6.88K, Segal Lloyd Mitchell sold 21.18K, and Segal Lloyd Mitchell sold 2.49K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RPTX?: Yes. Rallies tracks RPTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RPTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RPTX. It does not provide personalized investment advice.